"Sweden Pharmaceuticals & Healthcare Report Q2 2011" now available at Fast Market Research

March 22, 2011 - PRLog -- In BMI's Pharmaceuticals Business Environment Ratings for Q211, Sweden is the seventh most attractive Western European market surveyed, scoring 61.4 out of 100, above the regional average score 63.8. Globally, Sweden is placed 18th, below China and above Singapore, out of the total of 83 countries surveyed. While Sweden's pharmaceutical market is small compared with its Western European neighbours, BMI believes the country's high public expenditure on health and its favourable business environment are major factors in making it an attractive place in which to set up operations.

In 2010, expenditure on medicines in Sweden reached SEK30.57bn (US$3.85bn), compared with spending in the UK and Italy, which reached US$29.70bn and US$24.57bn respectively. In the same year, per-capita drug expenditure in Sweden reached US$410, comparing well with per-capita drug expenditure value in the UK (US$477) and Italy (US$406). Despite Sweden's small market size, high percapita drug expenditure levels translate into substantial revenue-earning opportunities for companies operating in the country.

Further attractions include a well developed healthcare system which enjoys high government contributions towards overall costs (public expenditure on healthcare in 2010 equated to US$40.73bn, accounting for nearly three quarters of total healthcare spending), along with a stringent regulatory climate (recognised by the US and the EU), large demand for patented products and a stable and transparent business environment. Sweden also has a favourable corporate tax environment compared with many of its European neighbours.

Sweden boasts a strong pharmaceutical and biotechnology industry. The leading local companies in terms of market capitalisation are Meda (US$2.43bn) and Swedish Orphan Biovitrum (US$1.20bn). A large number of foreign pharmaceutical firms are also already present on the Swedish market, including AstraZeneca, Pfizer, Roche and GlaxoSmithKline (GSK), with smaller players becoming increasingly involved through partnerships or similar collaborative deals.

Meda focuses on R&D of drugs in the areas of respiratory, cardiology, pain and inflammation, dermatology and the central nervous system. The company's products are sold in 120 countries globally, either through its own sales organisations (in more than 50 countries) or other pharmaceutical companies. Meda's shares are listed on the NASDAQ OMX Nordic Exchange in Stockholm.

Swedish Orphan Biovitrum is a niche specialty pharmaceutical company focused on providing and developing specialist pharmaceuticals for rare disease patients with high medical needs. Its portfolio consists of 60 marketed products and an emerging, late stage clinical development pipe-line. The company's shares are also are listed on the NASDAQ OMX Nordic Exchange in Stockholm.

For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/127257_sweden_pharmaceuticals_...


Partial Table of Contents:

SWOT Analysis
- Sweden Pharmaceuticals And Healthcare Industry SWOT
- Sweden Political SWOT
- Sweden Economic SWOT
Pharmaceutical Business Environment Ratings
- Table: Western Europe - Regional Pharmaceuticals Business Environment Ratings, Q211
- Rewards
- Risks
Sweden - Market Summary
Regulatory Regime
- Intellectual Property Regime
- Pricing Regime
- Reimbursement Regime
Industry Trends And Developments
- Epidemiology
- Healthc   are System
- Clinical Trials Sector
- Medical Devices Sector
Industry Forecast Scenario
- Overall Market Forecast
- Table: Pharmaceutical Sales Indicators 2007-2015
- Healthcare Expenditure Forecast
- Table: Healthcare Expenditure Indicators 2007-2015
- Table: Government Healthcare Expenditure Indicators 2007-2015
- Table: Private Healthcare Expenditure Indicators 2007-2015
- Macroeconomic Forecast
- Table: Sweden - Economic Activity, 2006-2015
- Prescription Drug Market Forecast
- Table: Prescription Drug Sales Indicators 2007-2015
- Patented Drug Market Forecast
- Table: Patented Drug Market Indicators 2007-2015
- Generic Drug Market Forecast
- Table: Generic Drug Sales Indicators 2007-2015
- OTC Medicine Market Forecast
- Table: OTC Medicine Sales Indicators 2007-2015
- Medical Device Market Forecast
- Table: Medical Devices Sales Indicators 2007-2015
- Pharmaceutical Trade Forecast
- Table: Exports and Imports Indicators 2007-2015
- Other Healthcare Data Forecasts
- Key Risks To BMI Forecasts
Competitive Landscape
- Pharmaceutical Manufacturing Sector
- Recent Pharmaceutical Industry Developments
- Pharmaceutical Distribution Sector
Company Profiles
- Indigenous Companies
- Meda
- Swedish Orphan Biovitrum
Country Snapshot: Sweden Demographic Data
- Section 1: Population
- Table: Demographic Indicators, 2005-2030
- Table: Rural/Urban Breakdown, 2005-2030
- Section 2: Education And Healthcare
- Table: Education, 2002-2005
- Table: Vital Statistics, 2005-2030
- Section 3: Labour Market And Spending Power
- Table: Employment Indicators, 2001-2006
- Table: Consumer Expenditure, 2000-2012 (US$)
- Table: Average Annual Wages, 2000-2012

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=1272...

About Business Monitor International

Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets.  BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports.  Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports.  View more research from Business Monitor International at http://www.fastmr.com/catalog/publishers.aspx?pubid=1010

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.